Admelog Injection, Solution
Product Images NDC 0024-5924

37 FDA label images from Sanofi-aventis U.s. Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 37 technical images submitted to the FDA as part of the official labeling for Admelog (NDC 0024-5924). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sanofi-aventis U.s. Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure 1 (0691def8 4a7b 4de3 866f A280989f47f1 01)

Figure 1 (0691def8 4a7b 4de3 866f A280989f47f1 01)
A line graph showing the glucose infusion rate (GIR) in mg/min/kg over time (hours) for ADMELOG insulin lispro injection. The x-axis represents time in hours from 0 to 12, and the y-axis shows GIR values up to 10 with a smoothing factor applied. The graph illustrates the pharmacodynamic profile of ADMELOG with a peak around 2 hours followed by a gradual decline.*
FDA Label Image

Figure 2 (0691def8 4a7b 4de3 866f A280989f47f1 02)

Figure 2 (0691def8 4a7b 4de3 866f A280989f47f1 02)
A pharmacokinetic graph showing mean plasma insulin lispro concentration (mU/L) over time (minutes) up to 480 minutes. The curve displays a rapid rise to peak concentration before gradually declining over the time course.*
FDA Label Image

Step 1 (0691def8 4a7b 4de3 866f A280989f47f1 03)

Step 1 (0691def8 4a7b 4de3 866f A280989f47f1 03)
A black and white instructional illustration showing two hands preparing a vial for use. One hand holds the vial steady while the other hand is removing a cap or lid from the vial. The image suggests handling or preparing an injectable medication.*
FDA Label Image

Step 2 (0691def8 4a7b 4de3 866f A280989f47f1 04)

Step 2 (0691def8 4a7b 4de3 866f A280989f47f1 04)
An instructional line drawing showing a hand peeling back the protective seal from the top of a small vial, which is held steady by another hand. The image likely demonstrates how to prepare an injection vial for use.*
FDA Label Image

Step 3 (0691def8 4a7b 4de3 866f A280989f47f1 05)

Step 3 (0691def8 4a7b 4de3 866f A280989f47f1 05)
An instructional illustration showing a hand holding a syringe filled with liquid, with an arrow indicating the needle being inserted or removed from a vial or container. This diagram likely demonstrates a step in preparing or handling an injectable solution, such as insulin lispro.*
FDA Label Image

Step 3 (0691def8 4a7b 4de3 866f A280989f47f1 06)

Step 3 (0691def8 4a7b 4de3 866f A280989f47f1 06)
An instructional diagram showing hands preparing a syringe for injection. One hand holds a vial, and the other hand is drawing liquid from the vial into the syringe, illustrating the preparation of a subcutaneous injection.*
FDA Label Image

Step 4 (0691def8 4a7b 4de3 866f A280989f47f1 07)

Step 4 (0691def8 4a7b 4de3 866f A280989f47f1 07)
Illustration showing a hand drawing insulin lispro injection solution from a vial into a syringe. The diagram highlights the correct technique for filling the syringe, including holding the vial upside down and pulling back the plunger to draw the medication.*
FDA Label Image

Step 5 (0691def8 4a7b 4de3 866f A280989f47f1 08)

Step 5 (0691def8 4a7b 4de3 866f A280989f47f1 08)
An illustration showing a hand holding a syringe and preparing to inject a solution into or near the skin, indicating subcutaneous injection technique. The image focuses on the injection step with a finger pointing to the injection site.*
FDA Label Image

Step 7 (0691def8 4a7b 4de3 866f A280989f47f1 09)

Step 7 (0691def8 4a7b 4de3 866f A280989f47f1 09)
An anatomical illustration showing recommended subcutaneous injection sites for ADMELOG insulin lispro 100 U/mL injection. The diagram highlights the upper arms, stomach, thighs, and buttocks as areas suitable for injection administration.*
FDA Label Image

Step 7 (0691def8 4a7b 4de3 866f A280989f47f1 10)

Step 7 (0691def8 4a7b 4de3 866f A280989f47f1 10)
An instructional illustration depicting a hand applying or holding a small adhesive bandage on a finger, likely demonstrating post-injection care or wound covering after administration.*
FDA Label Image

Step 8 (0691def8 4a7b 4de3 866f A280989f47f1 11)

Step 8 (0691def8 4a7b 4de3 866f A280989f47f1 11)
An instructional illustration showing a hand holding an insulin syringe, with an arrow indicating twisting or removal of the needle cap. The image likely demonstrates part of the preparation or usage process for an insulin injection, such as administering ADMELOG insulin lispro solution.*
FDA Label Image

Image (0691def8 4a7b 4de3 866f A280989f47f1 12)

Image (0691def8 4a7b 4de3 866f A280989f47f1 12)
An anatomical diagram illustrating recommended subcutaneous injection sites for ADMELOG insulin lispro. Highlighted areas include the upper arms, stomach, thighs, and buttocks on front and back views of the human body.*
FDA Label Image

Image (0691def8 4a7b 4de3 866f A280989f47f1 13)

Image (0691def8 4a7b 4de3 866f A280989f47f1 13)
An instructional diagram of the ADMELOG SoloStar insulin pen. It labels parts including the pen cap, cartridge holder containing the prefilled insulin lispro solution (100 U/mL), rubber seal, insulin scale, plunger (visible after a few doses), dose window, dose pointer, dose selector, and injection button, illustrating the key components of the subcutaneous injection device.*
FDA Label Image

Step 1a (0691def8 4a7b 4de3 866f A280989f47f1 14)

Step 1a (0691def8 4a7b 4de3 866f A280989f47f1 14)
ADMELOG SoloStar 100 U/mL injection pen, containing insulin lispro solution for subcutaneous use. The image shows a yellow pen device labeled for single patient use, with a capacity of 3 mL, manufactured by Sanofi-Aventis U.S. LLC.*
FDA Label Image

Step 1b (0691def8 4a7b 4de3 866f A280989f47f1 15)

Step 1b (0691def8 4a7b 4de3 866f A280989f47f1 15)
An instructional illustration showing a hand holding an ADMELOG insulin lispro 100 U/mL injection pen. The pen cap is being placed or removed, indicated by a blue arrow, demonstrating proper handling of the subcutaneous injection device.*
FDA Label Image

Step 1c (0691def8 4a7b 4de3 866f A280989f47f1 16)

Step 1c (0691def8 4a7b 4de3 866f A280989f47f1 16)
ADMELOG insulin lispro 100 U/mL injection, solution in a 3 mL prefilled pen for subcutaneous use. The pen label shows dosage markings from 10 to 30 units and partial prescribing information, labeled by Sanofi-Aventis U.S. LLC for single patient use.*
FDA Label Image

Step 1d (0691def8 4a7b 4de3 866f A280989f47f1 17)

Step 1d (0691def8 4a7b 4de3 866f A280989f47f1 17)
An instructional illustration showing hands preparing an injection device. It depicts one hand holding the injection pen labeled ADMELOG insulin lispro 100 U/mL and another hand peeling off a protective cap, suggesting preparation for subcutaneous administration.*
FDA Label Image

Step 2a (0691def8 4a7b 4de3 866f A280989f47f1 18)

Step 2a (0691def8 4a7b 4de3 866f A280989f47f1 18)
An instructional illustration showing a pair of hands holding a small vial with the cap being removed or twisted off, likely depicting the preparation step for injection solution.*
FDA Label Image

Step 2b (0691def8 4a7b 4de3 866f A280989f47f1 19)

Step 2b (0691def8 4a7b 4de3 866f A280989f47f1 19)
An instructional illustration demonstrating how to remove the cap from an ADMELOG insulin lispro 100 U/mL pen for subcutaneous injection. It shows hands twisting and pulling the protective cap off the pen, with a red circle indicating not to pull straight off without twisting.*
FDA Label Image

Step 2c (0691def8 4a7b 4de3 866f A280989f47f1 20)

Step 2c (0691def8 4a7b 4de3 866f A280989f47f1 20)
An instructional illustration showing a hand holding an ADMELOG insulin lispro injection solution pen with visible dosage markings, and a close-up inset of a hand removing the pen cap, demonstrating the preparation steps for subcutaneous injection.*
FDA Label Image

Step 2d (0691def8 4a7b 4de3 866f A280989f47f1 21)

Step 2d (0691def8 4a7b 4de3 866f A280989f47f1 21)
An instructional illustration showing a hand removing a protective cap from a vial, with a syringe prepared for injection. The image demonstrates removing the vial cap before drawing medication, relevant for subcutaneous injection preparation.*
FDA Label Image

Step 3a (0691def8 4a7b 4de3 866f A280989f47f1 22)

Step 3a (0691def8 4a7b 4de3 866f A280989f47f1 22)
Illustration showing two hands holding and operating an ADMELOG insulin lispro SoloStar injection pen. The image highlights adjusting the dose by turning the dial at the end of the pen, with a close-up of the dose display indicating the number '2'.*
FDA Label Image

Step 3b (0691def8 4a7b 4de3 866f A280989f47f1 23)

Step 3b (0691def8 4a7b 4de3 866f A280989f47f1 23)
An instructional illustration showing a person holding an ADMELOG insulin lispro injection pen vertically with the needle pointing upward. The diagram includes two close-up views: one focusing on the needle and another showing a drop of liquid being expelled, indicating priming or removing air from the pen prior to injection.*
FDA Label Image

Step 4a (0691def8 4a7b 4de3 866f A280989f47f1 24)

Step 4a (0691def8 4a7b 4de3 866f A280989f47f1 24)
ADMELOG insulin lispro 100 U/mL injection in a SoloStar prefilled pen for subcutaneous use. The image shows a syringe-like pen device with measurement markings and a protective cap on the needle end, labeled by Sanofi-Aventis U.S. LLC, intended for single patient use.*
FDA Label Image

Step 4b (0691def8 4a7b 4de3 866f A280989f47f1 25)

Step 4b (0691def8 4a7b 4de3 866f A280989f47f1 25)
Illustration showing a hand holding an insulin injection pen labeled SoloStar. It depicts a step in the injection process where the cap is being twisted and removed, indicated by a blue arrow pointing upwards. The image focuses on handling the pen for subcutaneous injection preparation.*
FDA Label Image

Step 4b (0691def8 4a7b 4de3 866f A280989f47f1 26)

Step 4b (0691def8 4a7b 4de3 866f A280989f47f1 26)
An instructional illustration showing a close-up view of a dosing dial on an insulin pen. The dial displays dose numbers 10 and 20, indicating units of insulin to be administered. The pen appears designed for subcutaneous injection.*
FDA Label Image

Step 4b (0691def8 4a7b 4de3 866f A280989f47f1 27)

FDA Label Image

Step 5b (0691def8 4a7b 4de3 866f A280989f47f1 28)

Step 5b (0691def8 4a7b 4de3 866f A280989f47f1 28)
An instructional illustration demonstrating the proper way to hold an ADMELOG insulin lispro injection pen for subcutaneous injection. The image shows a hand gripping the injection pen with the thumb positioned to press the dosage button, indicating the direction of injection with a left-pointing arrow.*
FDA Label Image

Step 5c (0691def8 4a7b 4de3 866f A280989f47f1 29)

Step 5c (0691def8 4a7b 4de3 866f A280989f47f1 29)
Instructional illustration showing how to properly hold and turn the dose knob on an ADMELOG insulin lispro injection pen to adjust the dose. The correct method is shown with a blue arrow and a thumbs-up, indicating the knob should be turned with the thumb from the side. An incorrect method is indicated with a red circle and a cross, warning against pressing the knob downward with the thumb.*
FDA Label Image

Step 5d (0691def8 4a7b 4de3 866f A280989f47f1 30)

Step 5d (0691def8 4a7b 4de3 866f A280989f47f1 30)
An instructional illustration showing a hand holding an ADMELOG insulin lispro injection pen. A clock indicates to hold the pen in place for 10 seconds after injection. The illustration emphasizes proper technique for subcutaneous administration of the insulin solution.*
FDA Label Image

Step 6a (0691def8 4a7b 4de3 866f A280989f47f1 31)

Step 6a (0691def8 4a7b 4de3 866f A280989f47f1 31)
Instructional illustration showing the steps to attach a needle to an ADMELOG insulin lispro 100 U/mL injection pen device. The syringe pen is held in one hand, with the other hand positioning a needle cap to be pushed onto the pen tip, indicated by a blue arrow.*
FDA Label Image

Step 6b (0691def8 4a7b 4de3 866f A280989f47f1 32)

Step 6b (0691def8 4a7b 4de3 866f A280989f47f1 32)
An instructional illustration demonstrating how to attach the needle cap to a pen injector for ADMELOG insulin lispro injection, 100 U/mL. The image shows hands holding the pen, with arrows indicating a twisting motion to secure the needle cap and pressing actions to attach or remove components, highlighting proper handling technique for subcutaneous injection.*
FDA Label Image

Step 6c (0691def8 4a7b 4de3 866f A280989f47f1 33)

Step 6c (0691def8 4a7b 4de3 866f A280989f47f1 33)
Illustration showing a person removing a cap from a bottle and holding a small vial above it, demonstrating the process of preparing or mixing an injectable solution. The image suggests a step in the handling or administration of a subcutaneous injection.*
FDA Label Image

Step 6d (0691def8 4a7b 4de3 866f A280989f47f1 34)

Step 6d (0691def8 4a7b 4de3 866f A280989f47f1 34)
An instructional illustration showing how to remove the yellow cap from an ADMELOG insulin lispro injection pen, with fingers holding the pen and an arrow indicating the direction to pull the cap off.*
FDA Label Image

Principal Display Panel (10 mL Vial Carton)

Principal Display Panel (10 mL Vial Carton)
Packaging label for Admelog (insulin lispro) injection 100 units/mL (U-100), a subcutaneous injection in a 10mL multiple-dose vial. Label indicates use for intravenous infusion after further dilution under medical supervision. Manufactured by Sanofi-Aventis U.S. LLC, Bridgewater, NJ. The label includes storage instructions, warnings, and a barcode.*
FDA Label Image

Principal Display Panel (3 mL Pen Carton)

Principal Display Panel (3 mL Pen Carton)
Packaging label for Admelog SoloStar insulin lispro injection 100 units/mL (U-100) prefilled pens. The box contains five 3 mL prefilled pens for subcutaneous use only. Label highlights single patient use, storage instructions, and manufacturer Sanofi-Aventis U.S. LLC. The design includes images of the yellow pen injector and clear dosage information.*
FDA Label Image

Principal Display Panel (3 mL Vial Carton)

Principal Display Panel (3 mL Vial Carton)
Packaging label for Admelog (insulin lispro) injection 100 units/mL (U-100), a 3mL multiple-dose vial for subcutaneous use. The label indicates use for intravenous infusion after further dilution only under direct medical supervision. Manufactured by Sanofi-Aventis U.S. LLC, Bridgewater, NJ. Includes storage instructions, warnings, dosage notes, and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.